GO:0015961 diadenosine polyphosphate catabolic process: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0015961 describes the biochemical breakdown of diadenosine polyphosphates (ApnA), a family of dinucleoside polyphosphates involved in cellular signaling.
• Diadenosine polyphosphates such as Ap4A act as extracellular and intracellular signaling molecules in the nervous system and other tissues.
• Catabolism of these molecules is essential to terminate their signaling actions and to maintain cellular homeostasis.
• Enzymes that hydrolyze diadenosine polyphosphates include Nudix hydrolases and other phosphohydrolases, some of which are regulated by cystathionine beta-synthase domains.
• Dysregulation of diadenosine polyphosphate metabolism has been linked to neurological and cardiovascular conditions, though direct disease associations require further study.
• CRISPR-based models (knockout, knock-in, overexpression) enable precise dissection of genes involved in diadenosine polyphosphate catabolism.
Description
Diadenosine polyphosphates (ApnA) are a family of dinucleoside polyphosphates that function as signaling molecules in both prokaryotic and eukaryotic cells. The catabolic process that removes these molecules, formally annotated as GO:0015961 diadenosine polyphosphate catabolic process, is critical for terminating their signaling actions and preventing their accumulation. This process involves enzymatic hydrolysis of the polyphosphate chain, yielding adenosine monophosphate (AMP) and other adenosine derivatives. Understanding this catabolic pathway is important because diadenosine polyphosphates such as Ap4A have been implicated in neurotransmission, platelet aggregation, and cellular stress responses. Moreover, enzymes that degrade these molecules are potential drug targets, and their dysfunction may contribute to disease. Researchers studying this process require reliable models to manipulate the responsible genes and to measure catabolic flux. This article provides a comprehensive overview of GO:0015961, covering its definition, mechanism, key genes, disease relevance, and experimental approaches, including CRISPR-based strategies.
diadenosine polyphosphate catabolic process At A Glance
| GO ID | GO:0015961 |
|---|---|
| GO term | diadenosine polyphosphate catabolic process |
| Ontology | biological_process |
| Synonym | diadenosine polyphosphate breakdown; diadenosine polyphosphate catabolism; diadenosine polyphosphate degradation |
| Major function | Breakdown of diadenosine polyphosphates (e.g., Ap4A) to terminate signaling and recycle nucleotides |
| Related enzymes | Nudix hydrolases, phosphohydrolases, and enzymes with cystathionine beta-synthase domains |
| Substrates | Diadenosine polyphosphates such as Ap4A, Ap5A, Ap6A |
| Products | Adenosine monophosphate (AMP), adenosine, and inorganic phosphate |
| Cellular location | Cytosol, extracellular space, and secretory vesicles |
What Is GO:0015961?
GO:0015961, diadenosine polyphosphate catabolic process, is defined as the chemical reactions and pathways resulting in the breakdown of diadenosine polyphosphate, a derivative of the nucleoside adenosine with phosphate groups attached. In simpler terms, it is the set of enzymatic steps that degrade molecules like Ap4A into simpler components, thereby regulating their availability and signaling duration.
Why Is diadenosine polyphosphate catabolic process Important in Cell Biology?
The catabolism of diadenosine polyphosphates is crucial for controlling the duration and intensity of purinergic signaling. These molecules act as extracellular messengers in the nervous system, where they modulate neurotransmitter release and vascular tone. By breaking them down, cells prevent excessive signaling that could lead to pathological states. Additionally, the enzymes involved in this process are conserved across evolution and are linked to stress responses and metabolic regulation. Thus, understanding GO:0015961 provides insights into fundamental cellular communication and potential therapeutic targets.
• Regulates extracellular levels of diadenosine polyphosphates, which act as signaling molecules in the brain and vasculature.
• Prevents accumulation of Ap4A, which can interfere with cellular metabolism and signaling.
• Enzymes in this pathway, such as Nudix hydrolases, are potential drug targets for neurological disorders.
• Diadenosine polyphosphates are stored in secretory vesicles and released upon stimulation, requiring rapid catabolism.
• The catabolic process is conserved from bacteria to humans, highlighting its fundamental importance.
• Dysregulation of Ap4A metabolism has been associated with migraine and cardiovascular conditions.
• Plant signaling also involves extracellular nucleotides, suggesting broader roles in stress responses.
• Research on this pathway can uncover new biomarkers for purinergic diseases.
• CRISPR screens can identify novel genes involved in diadenosine polyphosphate catabolism.
• Understanding catabolism aids in designing stable analogs for therapeutic use.
What Happens During diadenosine polyphosphate catabolic process?
Substrate recognition and binding
In simple terms: The enzyme grabs the diadenosine polyphosphate molecule.
The first step in catabolism involves specific binding of diadenosine polyphosphates (e.g., Ap4A) to the active site of hydrolytic enzymes. These enzymes, such as Nudix hydrolases, recognize the polyphosphate chain and adenosine moieties. The binding is often facilitated by conserved structural motifs that accommodate the unusual dinucleotide structure.
Hydrolytic cleavage of the polyphosphate chain
In simple terms: The enzyme cuts the phosphate chain, breaking the molecule apart.
Once bound, the enzyme catalyzes the hydrolysis of phosphoanhydride bonds within the polyphosphate chain. This cleavage can occur at different positions, yielding products such as AMP, ADP, or adenosine, depending on the specific enzyme and substrate. For example, some hydrolases cleave Ap4A into AMP and ATP, while others produce two ADP molecules.
Release of products and enzyme turnover
In simple terms: The breakdown products are released, and the enzyme is ready to act again.
After cleavage, the products (e.g., AMP, adenosine, inorganic phosphate) are released from the active site, allowing the enzyme to catalyze another round of hydrolysis. These products can then enter other metabolic pathways, such as adenosine salvage or purine recycling.
Regulation of catabolic activity
In simple terms: The speed of breakdown is controlled by various factors.
The activity of diadenosine polyphosphate catabolic enzymes can be regulated at multiple levels, including gene expression, post-translational modifications, and allosteric regulation by metabolites. Some enzymes contain regulatory domains such as cystathionine beta-synthase domains that sense cellular redox status or energy charge. This ensures that catabolism is tuned to cellular needs.
Key Genes Involved in GO:0015961 diadenosine polyphosphate catabolic process
The following genes and proteins are known to participate in or regulate the catabolism of diadenosine polyphosphates, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NUDT2 | Nudix hydrolase that hydrolyzes Ap4A to AMP and ATP | Model for studying Ap4A catabolism in vitro and in vivo |
| NUDT4 | Nudix hydrolase with specificity for diadenosine polyphosphates | Potential target for modulating Ap4A levels |
| NUDT5 | Hydrolyzes ADP-ribose and Ap4A | Linked to metabolic regulation |
| NUDT9 | ADP-ribose pyrophosphatase, may act on Ap4A | Studied in mitochondrial function |
| NUDT12 | Nudix hydrolase that degrades Ap4A | Role in cellular stress responses |
| NUDT15 | Hydrolyzes Ap4A and other nucleotides | Associated with drug metabolism |
| NUDT16 | Decaps Ap4A and other dinucleoside polyphosphates | Involved in RNA processing |
| NUDT18 | Nudix hydrolase with activity against Ap4A | Potential role in DNA repair |
| NUDT19 | Hydrolyzes Ap4A in peroxisomes | Linked to lipid metabolism |
| NUDT21 | Cleavage factor involved in mRNA processing, not directly Ap4A catabolism | May indirectly affect Ap4A levels |
| ENPP1 | Ectonucleotide pyrophosphatase/phosphodiesterase that hydrolyzes Ap4A | Regulates extracellular Ap4A signaling |
| ENPP3 | Ectonucleotidase that degrades diadenosine polyphosphates | Involved in purinergic signaling |
| CD39 (ENTPD1) | Ectonucleoside triphosphate diphosphohydrolase, may act on Ap4A | Modulates extracellular nucleotide levels |
| CD73 (NT5E) | Ecto-5'-nucleotidase, produces adenosine from AMP | Indirectly involved in Ap4A catabolism |
| AK1 | Adenylate kinase, interconverts adenine nucleotides | Affects Ap4A metabolism |
| AK2 | Adenylate kinase 2, mitochondrial | Potential role in Ap4A turnover |
| CBS | Cystathionine beta-synthase domain-containing proteins regulate Nudix hydrolases | Regulatory mechanism |
How Is diadenosine polyphosphate catabolic process Regulated?
The catabolic process of diadenosine polyphosphates is regulated at multiple levels. Enzyme activity can be modulated by the cellular energy status, as some Nudix hydrolases contain cystathionine beta-synthase (CBS) domains that bind adenosine nucleotides and respond to changes in AMP/ATP ratios. Additionally, the expression of genes encoding these enzymes can be induced under stress conditions, such as oxidative stress or DNA damage. Extracellular catabolism is regulated by the availability of ectoenzymes like ENPP1 and CD39, which are expressed on the cell surface and can be modulated by inflammatory signals. Overall, regulation ensures that diadenosine polyphosphate levels are kept within physiological ranges.
diadenosine polyphosphate catabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NUDT2 | Neurological signaling, potential role in migraine | Knockout mice, neuronal cell lines |
| ENPP1 | Cardiovascular calcification, insulin resistance | Knockout mice, vascular smooth muscle cells |
| CD39 | Thrombosis, inflammation | Knockout mice, endothelial cells |
| CD73 | Cancer immunosuppression | Knockout mice, tumor models |
| NUDT5 | Metabolic disorders | Knockout cell lines, metabolic assays |
Neurological disorders
Diadenosine polyphosphates act as neurotransmitters or neuromodulators in the central and peripheral nervous systems. Alterations in their catabolism could lead to prolonged signaling, which has been implicated in migraine, epilepsy, and neurodegenerative conditions. For example, Ap4A is stored in synaptic vesicles and released upon stimulation, and its breakdown is essential for terminating its action. Dysfunctional catabolic enzymes may contribute to pathological pain states.
Cardiovascular diseases
Diadenosine polyphosphates influence platelet aggregation and vascular tone. Ap4A is a potent vasoconstrictor in some vascular beds, and its catabolism by ectoenzymes regulates its bioavailability. Impaired breakdown could lead to thrombosis or hypertension. Thus, enzymes involved in GO:0015961 are potential targets for cardiovascular drug development.
Cancer and metabolic disorders
Altered levels of diadenosine polyphosphates have been observed in cancer cells, where they may affect proliferation and apoptosis. Some Nudix hydrolases are overexpressed in tumors, suggesting a role in tumor metabolism. However, direct evidence linking catabolic defects to cancer is still emerging. Metabolic disorders such as diabetes may also involve purinergic signaling dysregulation.
From diadenosine polyphosphate catabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does NUDT2 knockout affect Ap4A levels? | CRISPR knockout in HEK293 or neuronal cells |
| What is the effect of a point mutation in the catalytic site of NUDT2? | CRISPR point mutation (e.g., E52Q) |
| Can we tag NUDT2 with GFP to study localization? | Knock-in of GFP tag |
| Does overexpression of ENPP1 reduce extracellular Ap4A? | Overexpression in CHO or HEK293 cells |
| Which genes regulate Ap4A catabolism? | CRISPR library screening |
| Does a disease-associated SNP in NUDT5 alter enzyme activity? | Knock-in of SNP in cell lines |
How to Study the diadenosine polyphosphate catabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| HPLC | Substrate and product concentrations | Enzyme kinetics |
| LC-MS/MS | Metabolite levels | Quantification in cells/tissues |
| CRISPR knockout screen | Gene essentiality for catabolism | Discovery of novel regulators |
| Fluorescent sensor imaging | Real-time Ap4A dynamics | Live-cell imaging |
| Western blot | Protein expression levels | Validation of CRISPR models |
| Immunoprecipitation | Protein-protein interactions | Identifying regulatory complexes |
| RNA-seq | Transcriptional changes | Pathway analysis |
| Enzymatic assay | Catalytic activity | Characterization of mutants |
Biochemical assays for enzyme activity
Enzymatic activity of diadenosine polyphosphate hydrolases can be measured using purified recombinant proteins or cell lysates. Substrates such as Ap4A are incubated with the enzyme, and products are separated by HPLC or detected via coupled enzymatic assays. These methods allow determination of kinetic parameters and substrate specificity.
CRISPR-based genetic screens
Genome-wide CRISPR knockout or activation screens can identify genes that modulate diadenosine polyphosphate levels. Cells are infected with a library, selected, and then analyzed for changes in Ap4A catabolism using mass spectrometry or fluorescent reporters. This approach is powerful for discovering novel regulators.
Mass spectrometry for metabolite quantification
Liquid chromatography-tandem mass spectrometry (LC-MS/MS) enables sensitive and specific quantification of diadenosine polyphosphates and their catabolic products in cells and tissues. This method is essential for validating genetic models and measuring flux through the pathway.
Fluorescent and luminescent reporters
Genetically encoded fluorescent sensors for Ap4A or adenosine can be used to monitor catabolic activity in live cells. For example, a FRET-based sensor for Ap4A has been developed, allowing real-time imaging of intracellular levels. Such tools are valuable for high-throughput screening.
How CRISPR Can Be Used to Study GO:0015961 diadenosine polyphosphate catabolic process
Knockout
CRISPR knockout of genes such as NUDT2 or ENPP1 can abolish their catabolic activity, leading to accumulation of diadenosine polyphosphates. These models are useful to study the physiological consequences of impaired breakdown, including effects on signaling and disease phenotypes.
Point Mutation
Introducing specific point mutations in catalytic residues (e.g., in the Nudix motif) allows researchers to dissect the enzymatic mechanism and to create separation-of-function mutants. Such models can reveal whether catalytic activity is required for a particular phenotype.
Knock-in
Knock-in of tags (e.g., GFP, HA) or disease-associated variants enables visualization of protein localization and analysis of mutant behavior in a physiological context. For example, tagging NUDT2 can reveal its subcellular distribution.
Overexpression
Overexpression of catabolic enzymes can reduce diadenosine polyphosphate levels, providing a gain-of-function model to test sufficiency. This approach is useful for validating drug targets and for studying downstream effects of enhanced catabolism.
How EDITGENE Supports diadenosine polyphosphate catabolic process Research
Researchers studying diadenosine polyphosphate catabolic process-related genes often need to determine whether a candidate gene is causally involved in the pathway or merely correlated. EDITGENE provides a comprehensive suite of CRISPR services to enable such functional studies with high precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for diadenosine polyphosphate catabolic process research.
Frequently Asked Questions About diadenosine polyphosphate catabolic process
What is GO:0015961?
GO:0015961 is the Gene Ontology term for the diadenosine polyphosphate catabolic process, which describes the breakdown of diadenosine polyphosphates such as Ap4A.
What are diadenosine polyphosphates?
They are dinucleoside polyphosphates composed of two adenosine moieties linked by a polyphosphate chain, and they function as signaling molecules.
What genes are involved in diadenosine polyphosphate catabolic process?
Key genes include NUDT2, NUDT4, NUDT5, ENPP1, ENPP3, CD39, and CD73, among others.
Which enzymes degrade Ap4A?
Nudix hydrolases such as NUDT2 and ectoenzymes like ENPP1 hydrolyze Ap4A into AMP and other products.
Why is diadenosine polyphosphate catabolism important?
It terminates signaling by these molecules and prevents their toxic accumulation, thereby maintaining cellular homeostasis.
How is diadenosine polyphosphate catabolism regulated?
It is regulated by enzyme expression, post-translational modifications, and allosteric control via CBS domains.
What diseases are linked to diadenosine polyphosphate catabolism?
Dysregulation has been implicated in neurological disorders, cardiovascular diseases, and cancer.
How can I study diadenosine polyphosphate catabolism in the lab?
You can use biochemical assays, LC-MS/MS, CRISPR screens, and fluorescent sensors.
What CRISPR models are available for this pathway?
Knockout, point mutation, knock-in, and overexpression models can be generated for genes like NUDT2 and ENPP1.
Does EDITGENE provide services for this pathway?
Yes, EDITGENE offers custom CRISPR cell line generation, library screening, and bioinformatics for diadenosine polyphosphate catabolism research.
Conclusion
GO:0015961 diadenosine polyphosphate catabolic process is a fundamental biological pathway that controls the levels of signaling dinucleotides. Its importance spans neuroscience, cardiovascular biology, and cancer research. With the availability of CRISPR-based models and advanced analytical methods, researchers can now dissect the molecular players and their roles in health and disease. EDITGENE stands ready to support these efforts with tailored gene editing services.
References
- 1. Anashkin VA et al.. 2017. Enzymes Regulated via Cystathionine β-Synthase Domains.. Biochemistry (Mosc) 82(10):1079-1087 PMID: 29037129
- 2. Guranowski A. 2003. Analogs of diadenosine tetraphosphate (Ap4A).. Acta Biochim Pol 50(4):947-72 PMID: 14739989
- 3. Pintor J et al.. 2000. Diadenosine polyphosphate receptors. from rat and guinea-pig brain to human nervous system.. Pharmacol Ther 87(2-3):103-15 PMID: 11007994
- 4. Moriyama Y et al.. 2024. María Teresa Miras Portugal: a pioneer for vesicular nucleotide storage.. Purinergic Signal 20(2):93-98 PMID: 36525101
- 5. Bange G et al.. 2025. Dinucleoside Polyphosphates in Cellular Signaling: Function and Evolution Across Life.. Bioessays 47(10):e70049 PMID: 40776849
- 6. Miras-Portugal MT et al.. 2021. Geoffrey Burnstock, our friend and magister: the diadenosine polyphosphate connection.. Purinergic Signal 17(1):79-84 PMID: 33025428
- 7. Pietrowska-Borek M et al.. 2020. New Insight into Plant Signaling: Extracellular ATP and Uncommon Nucleotides.. Cells 9(2) PMID: 32024306
